Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On October 15, 2025, upon the recommendation of the Compensation Committee of the Board of Directors (the “ Board ”) of Kura Oncology, Inc. (the “
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Kura Oncology, Inc. 2023 Inducement Option Plan, as amended, and Forms of Stock Op